Study of the Levels of Serum Copeptin in Patients with Diabetic Retinopathy
Evit Ezzat Eid Iskandar;
Abstract
The prevalence of Diabetic retinopathy in Egypt among adult diabetic patients in 2010 was around 20.5%. 90 percent of all cases of blindness from diabetes can be prevented. It is the most common cause of preventable blindness among working age adults.
Copeptin, a novel biomarker (a surrogate to arginine vasopressin) was found to increase with diabetic retionopathy.
Our study aimed to measure the level of serum copeptin in patients with different degrees of diabetic retinopathy.
The study was conducted on 96 individuals in the diabetes and ophthalmology outpatient clinics between February and August 2017 after an informed oral consent. The groups were as follows:
Group I included 24 diabetic patients with no evidence of diabetic retinopathy.
Group II included 24 patients with non proliferative diabetic retinopathy.
Copeptin, a novel biomarker (a surrogate to arginine vasopressin) was found to increase with diabetic retionopathy.
Our study aimed to measure the level of serum copeptin in patients with different degrees of diabetic retinopathy.
The study was conducted on 96 individuals in the diabetes and ophthalmology outpatient clinics between February and August 2017 after an informed oral consent. The groups were as follows:
Group I included 24 diabetic patients with no evidence of diabetic retinopathy.
Group II included 24 patients with non proliferative diabetic retinopathy.
Other data
| Title | Study of the Levels of Serum Copeptin in Patients with Diabetic Retinopathy | Other Titles | دراسة مستوى الكوببتين في الدم في المرضى الذين يعانون من اعتلال الشبكية السكري | Authors | Evit Ezzat Eid Iskandar | Issue Date | 2017 |
Recommend this item
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.